2m 2m 2m 2m 2m 2m 2m
GYRE THERAP (GYRE)
NASDAQ
$5.86-$0.005 (-0.09%)
Price as of Oct 22, 2026 7:30 PM EDT- $625.6MMarket Cap
- -25.22%1-Year Change
- BiotechnologyIndustry
GYRE THERAP (GYRE)
$5.86-$0.005 (-0.09%)
GYRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.86 | ||
Change | -$0.27 (-4.38%) | ||
Open | $5.91 | ||
High | $6.00 | ||
Low | $5.80 | ||
Previous Close | $5.90 | ||
Volume | 66,577 | ||
30-Day Average Volume | 155,817 | ||
1-Week Change | -8.81% | ||
1-Month Change | -20.59% | ||
1-Year Change | -25.22% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 106.0M | ||
Total Assets | $199.3M | ||
Market Cap | $625.6M | ||
Enterprise Value | $582.3M | ||
Period: QTR TTM FY | |||
Revenue | $29.1M | ||
Net Income | -$11.7M | ||
Free Cash Flow | -$17.0M | ||
EBIT | -$11.8M | ||
EBITDA | -$10.3M | ||
Net Working Capital | $93.4M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 6 | ||
P/E | -49 | ||
PEG | 2 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 01/13/2023 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/13/2023 | ||
Earnings & Revenue